AKAN Stock Analysis: Buy, Sell, or Hold?
AKAN - Akanda Corp. Common Shares
$10.05
-0.11 (-1.08%)
▼
5d:
-26.21%
30d:
-31.4%
90d:
+1356.52%
HOLD
MODERATE Confidence
Analysis Updated: Jul 9, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When AKAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called AKAN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AKAN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AKAN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AKAN is currently trading at $10.05, which is considered oversold relative to its 30-day fair value range of $12.57 to $17.50.
Technical Outlook: Technically, AKAN is in a uptrend. The price is currently testing key support at $9.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AKAN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AKAN is in a uptrend. The price is currently testing key support at $9.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AKAN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.57 -
$17.50
Company Quality Score
44/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- CAUTION: 5-day price weakness (-26.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$12.57 -
$17.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.78
Resistance Level
$15.90
Current Trend
Uptrend
Technical data as of
Jul 9, 2026
Fundamental Context
Revenue Growth (YoY)
21.9%
Share & Embed Analysis
Last updated: July 10, 2026 9:29 AM ET
Data refreshes hourly during market hours. Next update: 10:29 AM
Data refreshes hourly during market hours. Next update: 10:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$196 | 64 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$118 | 58 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 49 HOLD |
